BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21487036)

  • 1. Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase.
    Brognard J; Zhang YW; Puto LA; Hunter T
    Cancer Res; 2011 Apr; 71(8):3152-61. PubMed ID: 21487036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical changes of ATP binding pocket may explain loss of kinase activity in mutant DAPK3 in cancer: A molecular dynamic simulation analysis.
    Agarwal T; Annamalai N; Maiti TK; Arsad H
    Gene; 2016 Apr; 580(1):17-25. PubMed ID: 26748242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of cytokinesis by cancer-associated DAPK3 mutations.
    Ono T; Terada F; Okumura M; Chihara T; Hamao K
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1095-1101. PubMed ID: 33032825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.
    Liu Y; Gao W; Siegfried JM; Weissfeld JL; Luketich JD; Keohavong P
    BMC Cancer; 2007 May; 7():74. PubMed ID: 17477876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Kake S; Usui T; Ohama T; Yamawaki H; Sato K
    Oncol Rep; 2017 Feb; 37(2):1100-1106. PubMed ID: 28075459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
    Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
    Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC).
    Ji M; Guan H; Gao C; Shi B; Hou P
    BMC Cancer; 2011 Apr; 11():147. PubMed ID: 21507233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
    Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
    Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation-dependent control of ZIPK nuclear import is species specific.
    Weitzel DH; Chambers J; Haystead TA
    Cell Signal; 2011 Jan; 23(1):297-303. PubMed ID: 20854903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats.
    Usui T; Okada M; Hara Y; Yamawaki H
    Hypertension; 2012 Oct; 60(4):1031-9. PubMed ID: 22868392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and functional interactions between ZIP kinase and UbcH5.
    Ohbayashi N; Okada K; Kawakami S; Togi S; Sato N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Kawai T; Akira S; Matsuda T
    Biochem Biophys Res Commun; 2008 Aug; 372(4):708-12. PubMed ID: 18515077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
    Burch LR; Scott M; Pohler E; Meek D; Hupp T
    J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.
    de Fraipont F; Levallet G; Creveuil C; Bergot E; Beau-Faller M; Mounawar M; Richard N; Antoine M; Rouquette I; Favrot MC; Debieuvre D; Braun D; Westeel V; Quoix E; Brambilla E; Hainaut P; Moro-Sibilot D; Morin F; Milleron B; Zalcman G;
    Clin Cancer Res; 2012 May; 18(10):2976-86. PubMed ID: 22434665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.
    Ogawa T; Liggett TE; Melnikov AA; Monitto CL; Kusuke D; Shiga K; Kobayashi T; Horii A; Chatterjee A; Levenson VV; Koch WM; Sidransky D; Chang X
    Cell Cycle; 2012 Apr; 11(8):1656-63. PubMed ID: 22487682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway.
    Takahashi M; Lio CJ; Campeau A; Steger M; Ay F; Mann M; Gonzalez DJ; Jain M; Sharma S
    Nat Immunol; 2021 Apr; 22(4):485-496. PubMed ID: 33767426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZIPK: a unique case of murine-specific divergence of a conserved vertebrate gene.
    Shoval Y; Pietrokovski S; Kimchi A
    PLoS Genet; 2007 Oct; 3(10):1884-93. PubMed ID: 17953487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers.
    Natrajan R; Mackay A; Lambros MB; Weigelt B; Wilkerson PM; Manie E; Grigoriadis A; A'Hern R; van der Groep P; Kozarewa I; Popova T; Mariani O; Turaljic S; Furney SJ; Marais R; Rodruigues DN; Flora AC; Wai P; Pawar V; McDade S; Carroll J; Stoppa-Lyonnet D; Green AR; Ellis IO; Swanton C; van Diest P; Delattre O; Lord CJ; Foulkes WD; Vincent-Salomon A; Ashworth A; Stern MH; Reis-Filho JS
    J Pathol; 2012 May; 227(1):29-41. PubMed ID: 22362584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway.
    Lin Y; Henderson P; Pettersson S; Satsangi J; Hupp T; Stevens C
    FEBS J; 2011 Jan; 278(2):354-70. PubMed ID: 21134130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4).
    Togi S; Ikeda O; Kamitani S; Nakasuji M; Sekine Y; Muromoto R; Nanbo A; Oritani K; Kawai T; Akira S; Matsuda T
    J Biol Chem; 2011 May; 286(21):19170-7. PubMed ID: 21454679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells.
    Tur MK; Neef I; Jost E; Galm O; Jäger G; Stöcker M; Ribbert M; Osieka R; Klinge U; Barth S
    J Immunother; 2009 Jun; 32(5):431-41. PubMed ID: 19609235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.